Immunohistochemical expression of apoptosis regulating proteins and sex hormone receptors in meningiomas

Neuropathology

Volumn 28, Issue 1, 2008, Pages 62-68

  Takei, Hidehiro ^a   Buckleair, Linda W ^b   Powell, Suzanne Z ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Apoptosis; bcl 2; Meningioma; Progesterone receptor; Proliferation index

Indexed keywords

APOPTOSIS REGULATING PROTEIN; ESTROGEN; ESTROGEN RECEPTOR; HORMONE RECEPTOR; INHIBITOR OF APOPTOSIS PROTEIN; KI 67 ANTIGEN; PROGESTERONE; PROGESTERONE RECEPTOR; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; REGULATOR PROTEIN; SEX HORMONE; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL PROLIFERATION; GENE EXPRESSION REGULATION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MENINGIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; TUMOR CELL;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS REGULATORY PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN;

EID: 37549065142     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2007.00852.x     Document Type: Article

References (36)

1. Central Brain Tumor Registry of the United States (CBTRUS). 2005-2006 Primary Brain Tumors in the United States, Statistical Report, 1998-2002 Years Data Collected. [Cited 16 Apr 2007.] Available from URL: http://www.cbtrus.org/ reports//2005-2006/2006report.pdf
2. Perry A, Louis DN, Scheithauer BW, Budka H, von Deimling A. Meningiomas. In : Louis DN, Ohgaki H, Wiestler OD, Cavanee WK, eds. World Health Organization Classification of Tumoursof the Central Nervous System. Lyon : IARC Press, 2007 164 192.
3. Perry A. Meningiomas. In : McLendon RE, Rosenblum MK, Bigner DD, eds. Ressell & Rubinstein's Pathology of Tumors of the Nervous System, 7th edn. New York : Hodder Arnold, 2006 427 474.
4. Roelvink NC, Kamphorst W, van Alphen HA, Rao BR. Pregnancy-related primary brain and spinal tumors. Arch Neurol 1987 44 : 209 215.
5. Smith JS, Quinones-Hinojosa A, Harmon-Smith M, Bollen AW, McDermott MW. Sex steroid and growth factor profile of a meningioma associated with pregnancy. Can J Neurol Sci 2005 32 : 122 127.
6. Jacobs DH, McFarlane MJ, Holmes FF. Female patients with meningioma of the sphenoid ridge and additional primary neoplasms of the breast and genital tract. Cancer 1987 60 : 3080 3082.
7. Schneider B, Pulhorn H, Rohrig B, Rainov NG. Predisposing conditions and risk factors for development of symptomatic meningioma in adults. Cancer Detect Prev 2005 29 : 440 447.
8. Blankenstein MA, Blaauw G, Lamberts SW. Progestin and estrogen receptors in human meningiomas. Clin Neuropharmacol 1984 7 : 363 367.
9. Blankenstein MA, Koehorst SG, van der Kallen CJ et al. Oestrogen receptor independent expression of progestin receptors in human meningioma - a review. J Steroid Biochem Mol Biol 1995 53 : 361 365.
10. Wahab M, Al-Azzawi F. Meningioma and hormonal influences. Climacteric 2003 6 : 285 292.
11. Korsmeyer SJ. Bcl-2 gene family and the regulation of programmed cell death. Cancer Res (Suppl) 1999 59 : 1693s 1700s.
12. Reed JC. Dysregulation of apoptosis in cancer. J Clin Oncol 1999 17 : 2941 2953.
13. Krajewski S, Blomqvist C, Franssila K et al. Reduced expression of proapoptotic gene bax in associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res 1995 55 : 441 448.
14. Mosnier JF, Perret AG, Brunon J, Boucheron S. Expression of the bcl-2 oncoprotein in meningiomas. Am J Clin Pathol 1996 106 : 652 659.
15. Konstantinidou AE, Pavlopoulos PM, Patsouris E, Kaklamanis L, Davaris P. Expression of apoptotic and proliferation markers in meningiomas. J Pathol 1998 186 : 325 330.
16. Ng H-K, Chen L. Apoptosis is associated with atypical or malignant change in meningiomas. An in situ labeling and immunohistochemical study. Histopathology 1998 33 : 64 70.
17. Karamitopoulou E, Perentes E, Tolnay M, Probst A. Prognostic significance of MIB-1, p53, and bcl-2 immunoreactivity in meningiomas. Hum Pathol 1998 29 : 140 145.
18. Abramovich CM, Prayson RA. Apoptotic activity and bcl-2 immunoreactivity in meningiomas. Association with grade and outcome. Am J Clin Pathol 2000 114 : 84 92.
19. Konstantinidou A, Korkolopoulou P, Patsouris E et al. Apoptosis detected with monoclonal antibody to single-stranded DNA is a predictor of recurrence in intracranial meningiomas. J Neurooncol 2001 55 : 1 9.
20. Verheijen FM, Donker GH, Sales Viera C et al. Progesterone receptor, bcl-2 and Bax expression in meningiomas. J Neurooncol 2002 56 : 35 41.
21. Konstantinidou AE, Korkolopoulou P, Mahera H et al. Hormone receptors in non-malignant meningiomas correlate with apoptosis, cell proliferation and recurrence-free survival. Histopathology 2003 43 : 280 290.
22. Das A, Tan WL, Smith DR. Expression of the inhibitor of apoptosis protein survivin in benign meningiomas. Cancer Lett 2003 193 : 217 222.
23. Castilla EA, Prayson RA, Abramovich CM, Cohen ML. Immunohistochemical expression of cathepsin D in meningiomas. Am J Clin Pathol 2003 119 : 123 128.
24. Kayaselcuk F, Zorludemir S, Bal N, Erdogan B, Erdogan S, Erman T. The expression of survivin and Ki-67 in meningiomas: correlation with grade and clinical outcome. J Neurooncol 2004 67 : 209 214.
25. DeLong MJ. Apoptosis: a modulator of cellular homeostasis and disease states. Ann NY Acad Sci 1998 842 : 82 90.
26. Maiuri F, De Caro MB, Esposito F, Cappabianca P, Strazzullo V, Pettinato G, de Divitiis E. Recurrences of meningiomas: predictive value of pathological features and hormonal and growth factors. J Neurooncol 2007 82 : 63 68.
27. Hara A, Hirose Y, Yoshimi N, Tanaka T, Mori H. Expression of Bax and bcl-2 proteins, regulators of programmed cell death, in human brain tumors. Neurol Res 1997 19 : 623 628.
28. Simonian PL, Grillot DA, Merino R, Nunez G. Bax can antagonize Bcl-XL during etoposide and cisplatin-induced cell death independently of its heterodimerization with Bcl-XL. J Biol Chem 1996 271 : 22764 22772.
29. Cheng EH, Levine B, Boise LH, Thompson CB, Hardwick JM. Bax-independent inhibition of apoptosis by Bcl-XL. Nature 1996 379 : 554 556.
30. Martin S, Toquet C, Cartron P-F et al. Expression of bcl-2, bax and bcl-xl in human gliomas: a re-appraisal. J Neurooncol 2001 52 : 129 139.
31. Deininger MH, Weller M, Streffer J, Meyermann R. Antiapoptotic Bcl-2 family protein expression increases with progression of oligodendroglioma. Cancer 1999 86 : 1832 1839.
32. Hsu DW, Efird JT, Hedley-Whyte ET. Progesterone and estrogen receptors in meningiomas: prognostic considerations. J Neurosurg 1997 86 : 113 120.
33. Roser F, Nakamura M, Bellinzona M, Rosahl SK, Ostertag H, Samii M. The prognostic value of progesterone receptor status in meningiomas. J Clin Pathol 2004 57 : 1033 1037.
34. Korhonen K, Salminen T, Raitanen J, Auvinen A, Isola J, Haapasalo H. Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expression. J Neurooncol 2006 80 : 1 7.
35. Omulecka A, Papierz W, Nawrocka-Kunecka A, Lewy-Trenda I. Immunohistochemical expression of progesterone and estrogen receptors in meningiomas. Folia Neuropathol 2006 44 : 111 115.
36. Pravdenkova S, Al-Mefty O, Sawyer J, Husain M. Progesterone and estrogen receptors: opposing prognostic indicators in meningiomas. J Neurosurg 2006 105 : 163 173.